Congress Asset Management Co. MA Has $25.29 Million Stock Holdings in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)

Congress Asset Management Co. MA boosted its holdings in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 19.1% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 917,164 shares of the specialty pharmaceutical company’s stock after buying an additional 147,105 shares during the […]

Related Keywords

United States ,Piper Sandler ,Frederickm Hudson ,Frank Mottola ,Securities Exchange Commission ,Campbell Newman Asset Management Inc ,Assetmark Inc ,International Biotechnology Trust ,Burney Co ,Quarter For Supernus Pharmaceuticals ,Supernus Pharmaceuticals Stock Performance ,Supernus Pharmaceuticals Inc ,Dimensional Fund Advisors ,Supernus Pharmaceuticals Profile ,Exchange Commission ,Supernus Pharmaceuticals ,Congress Asset Management Co ,Nasdaq ,News Ratings For Supernus Pharmaceuticals Daily ,Congress Asset Management ,Free Report ,Asset Management ,Biotechnology Trust ,Fund Advisors ,Newman Asset Management ,Get Free Report ,Director Frederick ,Visit Holdingschannel ,Supernus Pharmaceuticals Daily ,Nasdaq Supn ,Supn ,Medical ,86845910 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,